Biosurgery Market in LAMEA is expected to register a CAGR of 7.4% during the forecast period (2019-2025) - KBV Research

31-Dec-2019 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report LAMEA Biosurgery Market, published by KBV Research, the LAMEA Biosurgery Market would witness market growth of 7.4% CAGR during the forecast period (2019-2025).

The Brazil market dominated the LAMEA Adhesion Barriers Biosurgery Market by Country in 2018, and would continue to be a dominant market till 2025. The Argentina market is expected to witness a CAGR of 8.8% during (2019 - 2025). Additionally, The UAE market would witness a CAGR of 7.9% during (2019 - 2025).

The General Surgeries market dominated the South Africa Biosurgery Market by Application in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $76.1 million by 2025, growing at a CAGR of 7.4 % during the forecast period. The Orthopedic Surgeries market would grow at a CAGR of 7.6% during (2019 - 2025). Additionally, The Neurological Surgeries market is expected to witness highest CAGR of 9.3% during (2019 - 2025).

The Surgical sealants market dominated the Saudi Arabia Biosurgery Market by Product in 2018, thereby, achieving a market value of $49.3 million by 2025. The Soft Tissue Attachments market is experiencing a growth rate of 9.2% during (2019 - 2025). The Bone Graft Substitutes market is anticipated to grow at a CAGR of 9% during (2019 - 2025). Additionally, The Adhesion Barriers market is expected to witness significant CAGR of 8.7% during (2019 - 2025).

Structural Insights: https://www.kbvresearch.com/lamea-biosurgery-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.